Advertisement
Sitagliptin Coupon - Sitagliptin 100mg tablet
Sitagliptin

Januvia

Sitagliptin (Januvia) is an expensive drug used to treat type 2 diabetes. It helps to control blood sugar. This drug is more popular than comparable drugs. A generic version of Januvia may become available in 2022. It is covered by most Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower. Compare gliptins.
Sitagliptin Coupon - Sitagliptin 100mg tablet
Advertisement

Sitagliptin Latest News

Get the latest updates on this drug from the GoodRx medical team

5 Ways to Save More on Your Diabetes Meds

Dr. Sharon Orrange - October 06, 2015

More than 29 million Americans have diabetes. That’s more than 10% of the US—and that number continues to rise. More than 1.7 million adults were diagnosed with diabetes in 2012 alone.
Fortunately, several new medications for diabetes have recently been approved—Toujeo (a new insulin product), Synjardy (a new combination of empagliflozin/metformin) and others. These new drugs provide several benefits such as fewer side effects or foolproof self-dosing with an insulin pen. See More

FDA Issues Warning on Joint Pain with Diabetes Medications

The GoodRx Pharmacist - September 04, 2015

On August 28, 2015, the FDA issued a safety warning for a newer type of type 2 diabetes medication known as DPP-4 inhibitors or gliptins.

There have been reports that these medications can cause severe and possibly disabling joint pain.

Which medications contain gliptins (DPP-4 inhibitors)?

Why was a FDA safety warning issued for gliptin medications?

The FDA issued the warning due to continued reports of severe joint pain associated with the use of gliptin medications. See More

Is Trulicity Better Than Victoza or Bydureon?

Dr. Sharon Orrange - November 04, 2014

The newest of the injectable diabetes medications which also helped diabetics lose weight is Trulicity, just approved in September 2014. Given that Trulicity has a low incidence of hypoglycemia and mild gastrointestinal side effects it will become a good option for type II diabetics.

Is it better than the other new diabetes meds?
Trulicity lowered Hgb A1C slightly more than, or the same as, Bydureon, Victoza, and the oral pills Januvia and metformin (Glucophage). See More

What’s New in Diabetes Treatment?

Dr. Sharon Orrange - January 02, 2014

2013 was a year for many new treatments for type II diabetes. For healthcare workers and patients it’s hard to keep up with the newer medications for the treatment of adult onset diabetes, and treating diabetes is an art and not a “one-size fits all” algorithm. For our folks struggling with type II diabetes the outlook just got brighter because of a class of drugs known as incretin based drugs. Here is the down-low on these medications. See More

Invokana: The New Kid on the Block for Diabetes

The GoodRx Pharmacist - July 25, 2013

Invokana (canaglifozin) is now readily available at most pharmacies after receiving approval for the treatment of type 2 diabetes earlier this year. Here’s what you need to know.

What is Invokana?

Type 2 diabetes leads to elevated levels of glucose in the blood, because of the inability of your body either to make enough insulin or because your cells cannot use it properly. Invokana is a novel drug that works by blocking glucose from being reabsorbed by the kidney. See More

Newer Diabetes Medications Januvia and Byetta Linked to Pancreatitis

Dr. Sharon Orrange - March 13, 2013

The past few years have brought new players in the treatment for Type II Diabetes. These medications, with more coming down the pipeline, are called GLP-1 (glucagon-like peptide-1 receptor) agonists.

Now, treatment with the GLP-1 based therapies sitagliptin (Januvia) and exenatide (Byetta) in adults with type 2 diabetes has been associated with acute pancreatitis.

That’s not good, but why should we still like these new medications? GLP-1 based therapies work well to lower sugars, are associated with an average weight loss of 2 – 8 pounds (a huge plus for diabetics), a low risk of hypoglycemia, and a good side-effect profile. See More

New Injectables for Diabetes: Shots that aren’t insulin are becoming popular among diabetics

Dr. Sharon Orrange - February 02, 2012

No, it’s not insulin. New injections for diabetes may change the way we manage adult-onset diabetes. Approval of a new once-a-week injection called Bydureon is an exciting new option for blood sugar control. This new class of injectables may be popular for several reasons, not the least of which is they also result in weight loss. Yippee!

Though it sounds straight out of outer space, these drugs are called incretin mimetics, meaning they mimic the incretin hormones that tell your body to release insulin after eating. See More

What is Juvisync? A match made in heaven in a new diabetes and cholesterol combination pill.

Dr. Sharon Orrange - January 11, 2012

A new combination pill targeted at diabetes and cholesterol is hitting the market and you will be hearing about it. Juvisync is a combination medication that contains two previously approved medicines: the generic cholesterol medication simvastatin, and Januvia (sitagliptin) a diabetes medication.

What are the upsides of Juvisync?

1) First off, you kill two birds with one stone and treat diabetes and cholesterol in one pill. See More

Four Drugs Responsible for the Most Hospitalizations

Dr. Sharon Orrange - December 09, 2011

What are the most dangerous medications? Results from a recent study highlight four drugs that are responsible for a shocking number of negative effects. Data from 2007 – 2009 shows that these four drugs were involved in more than two-thirds of the hospitalizations of older patients for harmful drug reactions and incidents.

Researchers looked at emergency hospitalizations of adults aged 65 years and older that were attributed to the use of a drug, or a drug-specific adverse effect. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.